Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease
Închide
Articolul precedent
Articolul urmator
110 0
SM ISO690:2012
GAVRILIUC, Olga, ROTARU, Lilia, GAVRILIUC, Mihail, CALDAROV, Anastasia. Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease. In: Abstract book of European Academy of Neurology Congress: MDS, Ed. 2023, 27-31 august 2023, Copenhagen. Copenhagen: International Parkinson and Movement Disorder Society, 2023, p. 1390.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Abstract book of European Academy of Neurology Congress 2023
Congresul "Abstract book of European Academy of Neurology Congress "
2023, Copenhagen, Danemarca, 27-31 august 2023

Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease


Pag. 1390-1390

Gavriliuc Olga1, Rotaru Lilia1, Gavriliuc Mihail1, Caldarov Anastasia2
 
1 Diomid Gherman Institute of Neurology and Neurosurgery,
2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
Proiecte:
 
Disponibil în IBN: 4 decembrie 2023


Rezumat

Objective: Objective of this study was to investigate the potential correlation between hemoglobin levelsand Parkinson’s disease (PD) severity, and to compare them with a control group of healthy individuals. Background: Previous studies have suggested a possible link between anemia and Parkinson’s disease (PD).Some studies found that low hemoglobin (Hb) levels were associated with an increased risk of PD. However,the relationship between Hb levels and PD severity is not well understood. Method: This study included 58 patients with PD (56.9% female, 43.1% male) and 70 healthy controls. Hblevels were measured and compared between different stages of disease severity as measured by the Hoehnand Yahr (H&Y) scale, UPDRS III and between the PD group and the control group. Statistical analysesincluded the Mann-Whitney test, Kruskal-Wallis test, and Spearman’s correlation test. Results: The PD group and control group were homogeneous with respect to age (p=0.9). Hb levels did notdiffer signifi cantly between the different stages of disease severity (p=0.516) or between the PD group andthe control group (p=0.7). Additionally, there was no signifi cant correlation between Hb levels and diseaseseverity as measured by the UPDRS III (r=0.3, p=0.6). Conclusion: These results suggest that Hb level is not signifi cantly correlated with disease severity inpatients with PD. However, further research with larger sample sizes is needed to confi rm these fi ndings andto better understand the relationship between Hb levels and PD. To cite this abstract in AMA style: O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov. Correlation between hemoglobin level and diseaseseverity in patients with Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1).https://www.mdsabstracts.org/abstract/correlation-between-hemoglobin-level-and-disease-severity-in-patients-with-parkinsons-disease/. Accessed December 4, 2023. MDS Abstracts - https://www.mdsabstracts.org/abstract/correlation-between-hemoglobin-level-and-disease-severity-in-patients-with-parkinsons-disease/